Data Insights
                                    By  Company Name
                                
                                No Filter Selected
                                    By  Disease Name
                                
                                No Filter Selected
                                    By  Drug Name
                                
                                No Filter Selected
                                    By Themes
                                
                                No Filter Selected
                                    Showing 1 results out of 1                                
                                
                                                Data Insights
                                                
                                        NMDA Regulator by Boehringer Ingelheim International for Unspecified Central Nervous System Disorders: Likelihood of Approval
NMDA Regulator is under clinical development by Boehringer Ingelheim International and currently in Phase I for Unspecified Central Nervous System...